Security key
67080M103
Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)
CUSIP: 67080M103
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 103,174,603
- Total 13F shares
- 67,877,304
- Share change
- +2,519,885
- Total reported value
- $1,525,459,447
- Put/Call ratio
- 69%
- Price per share
- $22.47
- Number of holders
- 170
- Value change
- +$59,100,303
- Number of buys
- 91
- Number of sells
- 86
Report period
Q3 2024
Institutions
170
Top holders
10
NRIX full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Nurix Therapeutics, Inc. SEC filings
Nurix Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67080M103
Recent filing periods:
Top shareholders of NRIX - Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
6.6%
|
6,820,015
|
$142,333,712 | — | 30 Jun 2024 | |
| Redmile Group, LLC |
13F
|
Company |
4.3%
|
4,423,616
|
$92,320,866 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.9%
|
3,991,500
|
$83,302,605 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.8%
|
3,882,125
|
$81,019,949 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
3,625,014
|
$75,654,042 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.1%
|
3,201,865
|
$66,822,922 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.7%
|
2,835,119
|
$59,170,000 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
2,708,533
|
$56,527,084 | — | 30 Jun 2024 | |
| ARK Investment Management LLC |
13F
|
Company |
2.3%
|
2,323,332
|
$48,487,938 | — | 30 Jun 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.1%
|
2,189,192
|
$45,689,000 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
2%
|
2,055,916
|
$42,906,967 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
1,989,700
|
$41,525,039 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,321,734
|
$27,589,926 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,283,108
|
$26,778,464 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.1%
|
1,173,518
|
$24,491,321 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.1%
|
1,164,246
|
$24,296,680 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1%
|
1,048,394
|
$21,879,983 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
1,040,666
|
$21,718,699 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.95%
|
981,167
|
$20,476,956 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.88%
|
912,000
|
$19,033,440 | — | 30 Jun 2024 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.83%
|
858,067
|
$17,907,858 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.63%
|
650,000
|
$13,565,500 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
623,404
|
$13,010,441 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.58%
|
603,133
|
$12,587,023 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.58%
|
599,623
|
$12,514,132 | — | 30 Jun 2024 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.57%
|
583,490
|
$12,177,436 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
0.49%
|
507,536
|
$10,592,276 | — | 30 Jun 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.48%
|
500,000
|
$10,435,000 | — | 30 Jun 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.46%
|
474,679
|
$9,906,551 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.45%
|
464,507
|
$9,694,261 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.43%
|
440,500
|
$9,193,234 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.42%
|
438,089
|
$9,142,917 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.42%
|
432,289
|
$9,021,870 | — | 30 Jun 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.41%
|
418,928
|
$8,743,027 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.35%
|
365,298
|
$7,623,769 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
334,972
|
$6,990,866 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.31%
|
324,000
|
$6,761,880 | — | 30 Jun 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.31%
|
320,552
|
$6,690,000 | — | 30 Jun 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.31%
|
314,762
|
$6,569,083 | — | 30 Jun 2024 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.3%
|
306,003
|
$6,386,000 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.29%
|
301,887
|
$6,300,382 | — | 30 Jun 2024 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.28%
|
290,000
|
$6,052,300 | — | 30 Jun 2024 | |
| WestHill Financial Advisors, Inc. |
13F
|
Company |
0.27%
|
283,333
|
$5,913,160 | — | 30 Jun 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.23%
|
238,582
|
$4,979,206 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.22%
|
224,908
|
$4,693,830 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.21%
|
221,327
|
$4,619,094 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
209,136
|
$4,364,664 | — | 30 Jun 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.2%
|
203,273
|
$4,242,308 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.19%
|
200,097
|
$4,176,024 | — | 30 Jun 2024 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.17%
|
174,393
|
$3,639,582 | — | 30 Jun 2024 |
Institutional Holders of Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) as of Q3 2024
As of 30 Sep 2024,
Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) was held by
170 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,877,304 shares.
The largest 10 holders included
BlackRock, Inc., Redmile Group, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, Deep Track Capital, LP, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, T. Rowe Price Investment Management, Inc., STATE STREET CORP, and ARK Investment Management LLC.
This page lists
170
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
172
Q3 2024 holders
170
Holder diff
-2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.